| Symbol | Company | Weighting |
|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA CO NV | 2.22% |
| TNDM | TANDEM DIABETES CARE INC | 2.11% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.90% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.87% |
| DXCM | DEXCOM INC | 1.83% |
| ISRG | INTUITIVE SURGICAL INC | 1.83% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.83% |
| ICLR | ICON PLC | 1.82% |
| GKOS | GLAUKOS CORPORATION | 1.81% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.80% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.79% |
| LLY | ELI LILLY CORP | 1.79% |
| ARGX | ARGENX SE ADR | 1.79% |
| PEN | PENUMBRA INC | 1.78% |
| AZN | ASTRAZENECA PLC-ADR | 1.78% |
| GH | GUARDANT HEALTH INC | 1.77% |
| MRK | MERCK & CO. NEW | 1.76% |
| SMMT | SUMMIT THERAPEUTICS INC. | 1.75% |
| SNY | SANOFI- AVENTIS- ADR | 1.74% |
| CNTA | CENTESSA PHARMACEUTI | 1.73% |
| ALC | ALCON INC | 1.72% |
| PCVX | VAXCYTE INC | 1.71% |
| BSX | BOSTON SCIENTIFIC | 1.71% |
| IMVT | IMMUNOVANT INC | 1.71% |
| ITCI | INTRA-CELLULAR THERAPIES USD | 1.70% |
| ABT | ABBOTT LABORATORIES | 1.70% |
| ELV | ELEVANCE HEALTH INC | 1.70% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.70% |
| MRUS | MERUS NV | 1.69% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.69% |
| SYK | STRYKER CORP | 1.69% |
| MOH | MOLINA HEALTHCARE INC | 1.68% |
| BDX | BECTON DICKINSON & CO | 1.68% |
| CYTK | CYTOKINETICS INC | 1.66% |
| INSM | INSMED INC | 1.65% |
| MCK | MCKESSON CORP | 1.65% |
| TVTX | TRAVERE THERAPEUTICS INC | 1.64% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.62% |
| BIIB | BIOGEN INC | 1.61% |
| REGN | REGENERON PHARMACEUTICALS | 1.61% |
| ZTS | ZOETIS INC | 1.60% |
| RMD | RESMED INC | 1.59% |
| EWTX | EDGEWISE THERAPEUTICS | 1.59% |
| AXSM | AXSOME THERAPEUTICS INC. | 1.59% |
| COO | COOPER COS INC | 1.59% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.58% |
| IMTX | IMMATICS NV | 1.56% |
| HCA | HCA HOLDINGS INC | 1.56% |
| NUVL | NUVALENT INC | 1.55% |
| THC | TENET HEALTHCARE CORP | 1.48% |
| ABVX | ABIVAX SA | 1.47% |
| HUM | HUMANA INC | 1.46% |
| UNH | UNITEDHEALTH GROUP INC | 1.44% |
| GERN | GERON CORP | 1.43% |
| CI | THE CIGNA GROUP | 1.43% |
| ARVN | ARVINAS INC USD | 1.41% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.40% |
| NVO | NOVO NORDISK A/S | 1.39% |
| RVMD | REVOLUTION MEDICINES INC | 1.34% |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1.31% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.